Safety and Efficacy of Canagliflozin in Advanced CKD

Clinical trial NCT05309785 · COMPLETED

Trial details

NCT number: NCT05309785
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

ESRD CKD Stage 4 CKD Stage 5

Start date: 2022-11-24
Primary completion: 2026-04-30
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.